Next: Analyzing typing speed, speech and sleep patterns to identify cognitive decline, dementia, Parkinson’s, and more

By SharpBrains | November 19, 2020

AI May Help Iden­ti­fy Patients With Ear­­ly-Stage Demen­tia (The Wall Street Jour­nal): Researchers are study­ing whether arti­­fi­­cial-intel­li­­gence tools that ana­lyze things like typ­ing speed, sleep pat­terns and speech can be used to help clin­i­cians bet­ter iden­ti­fy patients with ear­­ly-stage dementia.

Read More

With two new funding mechanisms, The Chan Zuckerberg Initiative reaches out of neuroscience to expand its Neurodegeneration Challenge Network

By SharpBrains | February 21, 2018

___ RFA Now Open: CZI Neu­rode­gen­er­a­tion Chal­lenge Net­work (Chan Zucker­berg Ini­tia­tive release): “The Chan Zucker­berg Ini­tia­tive invites appli­ca­tions to join the CZI Neu­rode­gen­er­a­tion Chal­lenge Net­work, an inter­dis­ci­pli­nary col­lab­o­ra­tive ini­tia­tive to increase under­stand­ing of the fun­da­men­tal biol­o­gy of neu­rode­gen­er­a­tive dis­or­ders. Appli­ca­tions are being accept­ed for two fund­ing mechanisms:

Read More

Augmenting physiotherapy via neurofeedback and neurostimulation: Key neurotechnology patent #43

By SharpBrains | April 25, 2017
therapy control

Today we are shar­ing a fas­ci­nat­ing patent from Medtron­ic.  (As men­tioned, we are fea­tur­ing 50 foun­da­tion­al Per­va­sive Neu­rotech patents, from old­er to new­er by issue date) U.S. Patent No. 8,121,694: Ther­a­py con­trol based on a patient move­ment state Assignee(s): Medtron­ic, Inc. Inventor(s): Gre­go­ry F. Mol­nar, Steven S. Gill, Kei­th A, Miesel, Mark S. Lent, Tim­o­thy J. Deni­son, Eric J.…

Read More

Minimizing negative side-effects from electromagnetic neural stimulation: Key neurotechnology patent #39

By SharpBrains | April 7, 2017
neural stimulation system

Today we high­light a 2010 patent by Advanced Neu­ro­mod­u­la­tion Sys­tems address­ing a seri­ous con­cern dur­ing the use of elec­tro­mag­net­ic brain stim­u­la­tion methods–where unin­tend­ed stim­u­la­tion of neu­rons can cause seizures or migraine headaches. U.S. Patent No. 7,831,305: Neur­al stim­u­la­tion sys­tem and method respon­sive to col­lat­er­al neur­al activ­i­ty Assignee(s): Advanced Neu­ro­mod­u­la­tion Sys­tems, Inc. Inventor(s): Brad­ford E. Glin­er Tech­nol­o­gy Cat­e­go­ry: Transcranial…

Read More

Study debunks 4 common myths about brain training and lifelong cognitive enhancement

By Alvaro Fernandez | February 7, 2017

— If the media is your main source of infor­ma­tion about brain train­ing and cog­ni­tive enhance­ment, you will prob­a­bly believe the fol­low­ing: 1) All brain train­ing is the same… 2) …and it sim­ply does­n’t work. 3) Com­mer­cial brain train­ing pro­grams, espe­cial­ly, don’t work. 4) How could they work? Genet­ics is des­tiny, aging is a pre­de­ter­mined process…so by age 60…

Read More

Philips ranked #18 Holder of Pervasive Neurotech Intellectual Property*

By SharpBrains | July 10, 2015

Dutch multi­na­tion­al com­pa­ny Philips is known for its health­care, light­ing, and con­sumer lifestyle prod­ucts. Includ­ed in these prod­ucts are a num­ber of health mon­i­tor­ing and com­mu­ni­ca­tion appli­ca­tions that relate to non­in­va­sive neu­rotech­nol­o­gy. A recent part­ner­ship with Emo­tiv explores the brain-con­trolled electronics

Read More